Sökning: "Renal impairment"
Visar resultat 1 - 5 av 64 avhandlingar innehållade orden Renal impairment.
1. Epidemiological Aspects of Renal Impairment in Patients with Type 2 Diabetes
Sammanfattning : Diabetes is a leading cause of renal impairment (RI) and indication of the need for renal replacement therapy in many parts of the world. Albuminuria and RI are the two main forms of diabetic kidney disease. LÄS MER
2. Renal hemodynamics in renal artery stenosis and angiotensin II-dependent hypertension. Pathophysiological and diagnostic aspects
Sammanfattning : Patients with renovascular hypertension have a poor renal and cardiovascular prognosis. To improve the care of these patients, we need to increase knowledge about the pathophysiological mechanisms involved. LÄS MER
3. Potentially inappropriate drug treatment among older people with cognitive impairment
Sammanfattning : Background: The aging process contributes to alterations in organ systems, which lead to an increased risk for chronic conditions. Drug treatment is an important strategy in the management of chronic conditions; however, pharmacokinetic and pharmacodynamic alterations contribute to increased sensitivity to drug effects. LÄS MER
4. Children with symptomatic urinary tract infection in Göteborg 1970-79 followed for two decades
Sammanfattning : Objective: To study a populationbased cohort of subjects, detected after their first known urinary tract infection (UTI) with special focus on: the natural course of vesicoureteral reflux; the prevalence of renal scarring, age at detection and factors of importance for its development; the long term risk of impaired renal function and hypertension. Methods: Analyses of data, prospectively registered during childhood, and an adulthood follow-up investigation evaluating renal function by 51Cr-EDTA clearance and blood pressure by 24-hour ambulatory technique. LÄS MER
5. Therapy with 177Lu-octreotate - pharmacokinetics, dosimetry and kidney toxicity
Sammanfattning : 177Lu-octreotate is used for treatment of patients with somatostatin receptor expressing neuroendocrine tumors in some clinics using a standard schedule. Renal and bone marrow toxicity are the main limiting factors. LÄS MER